PHI news
This article discusses strategies to promote equity in COVID-19 antiviral treatment. It highlights the disproportionate effect of the pandemic on marginalized groups and the need to address inequities in access to antiviral medications. The authors discuss barriers to equity, such as low awareness, limited access to healthcare, scarcity of therapeutics, and treatment prioritization. They propose strategies to overcome these barriers, including community-driven outreach campaigns, addressing healthcare costs for uninsured patients, transparent allocation of therapeutics, and monitoring data to ensure equity. The article emphasizes the importance of proactive and transparent approaches to promote health equity in COVID-19 treatment.
Resource Details
- Population: People Experiencing Poverty|Uninsured People
- Setting/Context of Implementation: Clinical
- Topics of Practice: Organizational Change/ Development
- Outcomes of Interest: Reduction of Health Disparities
- Level of Evidence: Promising
- Tools or Materials Included in Resource: No
- Social Determinants of Health: Healthcare Access and Quality
- Outside of US: No